Object. Data analysis was performed in a multicenter study to evaluate magnetic resonance (MR) imaging for classification of brain tumors, prognosis, and prediction of tumor histological diagnosis.
UMORS of the central nervous system are the second most common malignant diseases in childhood; two thirds of these tumors are primary brain tumors. Ten to 15% of brain tumors are located in the brainstem, the majority of these being gliomas, 20 ,31 which in turn account for about 20 to 25% of all infratentorial tumors. 8, 11 For the purposes of this study, brainstem gliomas have been narrowly defined as being located exclusively in the mesencephalon, the pons (including the cerebellar peduncle), and the medulla oblongata. Cases involving quadrigeminal plate tumors and thalamic tumors have been excluded from the study. Several authors 2, 16, 17 have proposed classifying tumors according to their CT imaging characteristics, with the goal of defining subgroups that have different prognoses. A simple staging system based on size, location, and evidence of dissemination was first suggested by Epstein 16 to distinguish cases with a poor prognosis from those with a good prognosis. This system was used by Barkovich and colleagues 4 to describe a method of categorizing brainstem tumors on the basis on MR imaging findings. The researchers showed that MR imaging is highly sensitive and allows precise identification of both the location and extent of brainstem gliomas to identify subsets of tumors on the basis of growth characteristics and prognosis. Although there is no doubt that MR imaging is the most sensitive method for detecting brainstem lesions, the specificity of this modality has not been well established until now. In contrast to other researchers [1] [2] [3] 6, 9, 16, 20, 22, 25, 29, 30, 34 who do not see a general need for biopsy, pediatric neurosurgeons and neuropathologists 5 have advocated biopsy in cases in which brainstem tumors are suspected. 38 The question arises whether MR imaging can be used not only to classify brainstem tumors according to prognosis and recommended therapy but also to predict the histological characteristics of the lesions. Because biopsy is associated with a considerable morbidity rate 25, 26, 40, 42 and diag-nosis may remain uncertain even after a surgical or stereotactic biopsy specimen is performed, 1, 23, 30, 39 a multicenter study (involving eight centers) was performed with the goal of obtaining more data on the necessity of histological examination and comparative reliability of MR imaging for diagnosis. The question we asked was whether MR imaging can effectively replace biopsy. The study was performed as a blinded review.
Clinical Material and Methods
This study included 142 children (Յ 18 years of age) suffering from brainstem disease who were treated at one of eight German university hospitals (see Appendix for details). Patients were enrolled in the study if a clinical diagnosis of brainstem disease was confirmed by MR imaging, regardless of whether a tumor or a nontumorous lesion was suspected. In addition, all children enrolled in the study underwent either open or stereotactic biopsy.
Brainstem lesions were defined by location in the mesencephalon, pons (including the brachia pontis), or medulla oblongata. Patients were included only if the first diagnosis had been established at such a time that the MR imaging investigation was performed with second-or third-generation units. The location and extent of disease were assessed by at least one MR imaging investigation. The MR imaging studies were performed prior to therapy on a variety of 1.0-to 2-tesla MR imaging units (in the majority of cases, a 1.5-tesla unit was used) using a standard investigation technique with short T 1 -weighted images with and without intravenous administration of contrast medium (Gd-diethylenetriamine pentaacetic acid), long T 2 -weighted images in at least two planes, and fluid-attenuated inversion-recovery turbo spin echo images. Patients were excluded if the primary site of their lesion was outside the brainstem or if, as judged by the raters, the MR imaging and/or clinical data were incomplete, if the brainstem process was incompletely delineated, or if the quality of the MR images was below the normal diagnostic standard. Data availability varied: patients' age and sex, duration of illness, clinical conditions, and symptoms were available for 142 cases; histopathological findings for 126; MR imaging for 131.
Data collection was approved by the local ethics committees and authorized by the parents of the children by written informed consent.
The clinical data were evaluated by a team of pediatric neurologists and neurosurgeons using a questionnaire that included 18 items (the 17 signs and symptoms listed in Table 1 as well as a question about their duration). In 48 (38%) of 126 cases biopsy specimens were obtained by open surgery, in 78 (62%) of 126 cases stereotactic biopsies were performed as described by Ostertag and colleagues. 32 In nine (7%) of 126 cases we were unable to determine whether patients underwent open or stereotactic biopsy.
The diagnosis and description of histopathological findings were evaluated by neuropathologists using a questionnaire that addressed polymorphism, hyperchromatism, endothelial proliferation, cysts, Rosenthal fibers, necrosis, calcification, perivascular rosettes, rate of mitosis, cell density, giant cells, pseudopalisades, and inflammation. According to the neuropathological findings, four main diagnostic groups were defined: gliomas (astrocytoma, oligoastrocytoma, ganglioglioma, and GBM); nongliomatous tumors (ependymoma, medulloblastoma, plexus papilloma, and schwannoma); tumors originating outside the brain (sarcoma); and nontumorous lesions (inflammation, demyelinization, mitochondrial encephalopathy, abscess, encephalitis, intracerebral hemorrhage, and vascular malformation).
The MR images were assessed by three independent board-certified neuroradiologists (M.W.M, L.S., and M.S., are referred to as Observers 1, 2, and 3, respectively), all of whom were heads of academic departments of neuroradiology. The MR images were evaluated independently by each observer twice, both times in random order-first under blinded conditions and again (after being randomized a second time) with knowledge of the patients' clinical history and symptoms. This second evaluation was performed to assess whether knowledge of the clinical findings in an individual case influences the observer's diagnosis. In addition to giving diagnoses, the observers had to describe the imaging characteristics using a questionnaire covering primary location of the lesion as well as 14 individual items ( Table 2 ). The description of tumor characteristics followed the classification system described by Barkovich et al., 4 and Fischbein et al. 20 The findings regarding sensitivity, specificity, and predictive value refer in each instance to the group of those patients for whom both an assessment from the appropriate rater and also confirmation of the diagnosis by biopsy were available. Sensitivity, specificity, and predictive value were determined using four-field table methods. Analysis of interobserver agreement for blinded and nonblinded conditions was not performed due to the small number of cases in the nontumor category. Disagreement, especially with respect to the nontumor group and the estimation of WHO tumor grades, was taken into account.
Results

Clinical Data
The distribution of the children's ages is shown in Fig. 1 (mean 6.9 years, median 6 years). The 142 patients includ- ed 75 boys (53%) and 67 girls (47%). The median duration of symptoms was 6 weeks (range 0-260 weeks). The most common clinical symptoms were ataxia, headache, and vomiting, often occurring in combination (Table 1 ). An unexpectedly large number of children suffered from torticollis (37%) and personality change (44%), the latter most likely due to hydrocephalus. Cranial nerve deficit was present in 96 patients (68%); the facial nerve was involved most often (32 [33%] of the 96 cases), followed by the abducent nerve (22 cases [23%]).
Magnetic Resonance Imaging
For evaluation of MR imaging characteristics, 131 of the 142 sets of MR images could be included in the study. Six sets of MR images were rejected by the raters because of poor quality, incomplete investigation, or because the primary site of the lesion was found to be outside the brainstem.
An analysis of MR imaging characteristics following the detailed list of items shown in Table 2 was performed in 78 cases of glioma, the largest subgroup for which complete clinical data, MR images, and histological diagnoses were available. The primary site of the lesions was pontine in 48 of these cases (62%), the mesencephalon in 16 cases (20%), and the medulla oblongata (including the cervicomedullary junction) in 14 cases (18%). Extension of the tumor from the primary location into neighboring structures was present in 14 cases (18%).
Tumors were identified in 99, 96, and 95% of the cases by Observers 1, 2, and 3, respectively. Lesions were correctly diagnosed as glioma in 85, 91, and 87% of the cases (Table 3 ). The sensitivity for MR imaging diagnosis of brainstem tumors was 0.94, and the specificity was 0.43; the positive predictive value was 0.96, and the negative predictive value was 0.45.
For the subgroup of 78 cases of brainstem glioma, we evaluated the correlations between location and tumor grade, contrast enhancement and tumor grade, and brainstem enlargement and tumor grade (Fig. 2 ).
There was a high level of interobserver agreement in the general discrimination between tumors and nontumorous lesions and in estimates of WHO grade in high-grade pontine tumors, (Grade III range 80-93%, Grade IV range 83-89%). However, a distinct difference was found in the assessment of WHO tumor grades for tumors not located in the pons and for low-grade tumors (Table 4 ). Whether the raters had knowledge about the clinical data or not had no influence on these results. Therefore only the results of the blinded MR imaging evaluations are presented.
Within the small group of four nontumorous lesions, the highest proportion of correct diagnosis among the three observers was three of four (Table 5) .
Biopsy Complications and Findings
The overall morbidity rate associated with biopsy in our study was 3.2%. Two patients experienced drowsiness over the course of 2 days and in two others small intracerebral hematomas developed along the trajectory, but resolved spontaneously concomitantly with clinical improvement. A conclusive histological diagnosis could be made in 119 of the 126 cases in which biopsy specimens were obtained (Table 6 ). In six of the biopsies that were categorized as nondiagnostic, the diagnosis of tumor could be confirmed, but classification was not possible. The underrepresentation of nontumorous lesions in our study was due to selection for biopsy on the basis of imaging findings. Biopsy was only performed when there was suspicion of tumor.
Discussion
The role of neuroimaging in the differential diagnosis of brainstem tumors in children remains controversial even though MR imaging provides very precise delineation of the characteristics of tumorous and nontumorous lesions (Table 7) . On the basis of morphological findings on MR imaging that have been described by Barkovich and colleagues, 4 it has been shown that the nontumorous brainstem lesions most commonly seen in children-such as vascular malformations and inflammatory, infectious, and demyelinating lesions-may be distinguished from tumors by careful analysis of all anatomical details and contrast enhancement characteristics. Moreover, there have been advances in the use of MR imaging for differentiating malignant from nonmalignant brain tumors (Table 7) , allowing identification of lesions that are associated with much better prognoses and longer survival times. 2, 29 Because brainstem tumors in children have a poor prognosis, with patients usually surviving only 12 to 15 months after diagnosis, 16, 17, 21, 28, 39 tumors must be diagnosed using methods that provide maximum reliability of results with a minimum of stress to the patient.
Therefore, the primary purposes of imaging are the differentiation of nontumor diseases from tumors and the definition within the tumor group of criteria for poor or more favorable prognosis. The 5-year survival rate for patients with brainstem tumors (all types) ranges from 25 to 30%, 4,13, 17,30 depending on tumor location, regardless of histological characteristics. 1, 12, [16] [17] [18] 35 Only pilocytic astrocytomas and gangliogliomas differ from other brainstem tumors as a separate histological group associated with a long survival time. Identifying these tumors is crucial-and they can be identified by imaging (Fig. 3) .
Primary pontine tumors are associated with the least favorable prognosis; the mean survival time among patients with these tumors is less than 2 years. 4, 39 Even the use of hyperfractionated radiotherapy has not resulted in appreciable benefits for children with diffuse brainstem tumors (mean survival time 10 months), 21 so biopsy of such tumors should be avoided. Because radiotherapy in diffuse tumors is of no benefit and resection may be regarded as the only treatment option, there is no reason to perform a biopsy before resection. Unfortunately, no real benefit has been shown for surgery either, and to date the experimental use of alternative therapies involving high-dose chemotherapy with stem cell rescue, gene therapy, and immunotherapy has had little effect on the outcome in cases of diffuse brainstem tumors. 14, 33 In light of the dismal prospects for treatment success, there is no actual need for histological clarification in these cases and therefore no valid justification for performing a biopsy.
Clinical Data
In differentiating treatable from untreatable brainstem tumors, not only the morphological characteristics of the lesions on imaging but also the clinical data should be taken into account. There is no disagreement in the literature that prognostically favorable clinical factors can be distinguished from unfavorable factors. The favorable factors include a long duration of symptoms, focal tumor growth, exophytic components, and location of the primary tumor in the medulla oblongata or mesencephalon. By contrast, a short duration of symptoms, cranial nerve involvement, primary tumor location in the pons, diffuse growth, pronounced enlargement of the brainstem, and a high WHO grade must be considered unfavorable. 1, 2, 4, 5, 15, 18, 20, 28, 33, 37 Our clinical data agree with those reported by Behnke and colleagues 5 in their metaanalysis with respect to age distribution (median age 6 years) and gender distribution. The short duration of symptoms (mean 6 weeks) in our patient group must be regarded as a practically certain indicator 1 of poor prognosis and is in keeping with the high proportion of pontine tumors (62%) ( Fig. 2A) and the inhomogeneous internal structure of the lesions and marked enlargement of the brainstem that were identified on the MR images (Fig. 3) .
In addition to the known primary symptoms of ataxia, headache, and vomiting, personality changes and torticollis were also frequently observed in our patient group (Table  1) . The severity of the clinical symptoms did not correlate with tumor size or histological grade. Torticollis occurred exclusively in patients with medullary or cervicomedullary tumors. The involvement of cranial nerves was detectable in standard MR imaging studies in less than one third of the cases in which cranial nerve deficits were clinically evident (20% as opposed to 66%). This finding emphasizes the importance of clinical symptoms.
A Comparison of MR Imaging and Biopsy Findings
The superiority of MR imaging in the diagnosis of brain-
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* Only standard features were considered, without differentiating atypical appearance, variants, or subtypes. The individual case can differ widely from the standard. Abbreviations: ADEM = acute disseminated encephalomyelitis; FLAIR = fluid-attenuated inversion recovery; high = hyperintense signal; iso = isointense signal; low = hypointense signal; MS = multiple sclerosis; ϩ = yes; Ϫ = no. stem lesions has become so compelling 4, 6, [10] [11] [12] 17, 20, 24, 27, 34 that only MR imaging-based studies are justified and CT findings can be ignored.
Brainstem gliomas constituted 62% of the tumors from which biopsy specimens had been obtained in our study. We therefore chose this tumor subgroup to analyze the suitability of imaging parameters for classification of the brainstem lesions. The next two largest groups, medulloblastomas (10%) and ependymomas (8%), have their own characteristic appearance and can thus be easily differentiated from brainstem gliomas. Four MR imaging characteristics were frequently observed in brainstem tumors (Fig. 4) : inhomogeneous internal structure of the tumor (90%), blurring (78%) and irregularity (79%) of the tumor margins, and enlargement of the brainstem (78%) ( Table 2 ). Our findings agree with previous reports 1, 7, 19, 28 in identifying these four growth characteristics as the most important and most reliable diagnostic criteria for gliomas (Fig. 4) .
Analysis of the relationship between degree of brainstem enlargement and histological grade revealed that enlargement of the brainstem is not associated in any regular way with increased WHO grade, but that moderate to pronounced enlargement of the brainstem occurs in tumors of all grades. In our study, the most pronounced brainstem enlargement actually occurred in WHO Grade II tumors (Fig.   2C) . Likewise, the proportion of tumors without any enlargement of the brainstem in the WHO Grade I group did not differ significantly from that in the WHO Grade IV group. Thus, there is some doubt concerning the statement FIG. 3 . Magnetic resonance images showing pilocytic astrocytomas in three patients: a 2-year-old girl (A), a 5-year-old boy (B), and a 7-year-old boy (C). The lesions typically appear as mixed cystic/solid well-delineated masses with little or no surrounding edema. These tumors are typically focal and tend to grow more within one portion of the brainstem in contrast to malignant tumors, which may cross anatomical barriers such as the decussation pyramids. There is some similarity to a hemangioblastoma; however, the solid tumor parts are usually larger in pilocytic astrocytomas (A and B). Even large tumors (C) can be resected by open surgery obviating the need for biopsy.
FIG. 4. Magnetic resonance images demonstrating a Grade III
anaplastic astrocytoma in a 7-year-old boy. The T 2 -weighted image (left) shows the heterogeneous signal intensity, blurred tumor margins, and marked brainstem enlargement typical of high-grade gliomas. Contrast enhancement is present in some segments only (right). These characteristics indicate a high probability of a malignant brainstem tumor with no need for biopsy and histological verification.
that all diffuse brainstem tumors are malignant in terms of histological characteristics. 1 Because of the location, however, there is ultimately little difference in terms of prognosis or course of disease between diffuse brainstem tumors that are classified as malignant based on their histological characteristics and those that are not. Our results agree with those of Behnke and associates, 5 who found that of 30 diffuse-growing tumors, only five were malignant and that nine were Grade I and II astrocytomas with a diffuse growth pattern. Magnetic resonance imaging studies that show diffuse brainstem enlargement reliably support the diagnosis of a brainstem tumor-usually a glioma-but do not prove malignancy. The lack of consistent association between malignancy and diffuse tumor growth is also confirmed by the exclusively focal growth of the 12 medulloblastomas in our study. Like other authors, 3, 4, 12, 18 we found that tumors with a higher degree of malignancy were more frequently located in the pons than in other sites ( Fig. 2A) . Higher histological grade and so-called "malignancy of site" both contribute to the overall poorer prognosis associated with pontine brainstem tumors.
Investigators who have studied contrast enhancement in brainstem tumors 10, 18, 39 have noted that in these tumors, unlike supratentorial tumors, enhancement is not closely correlated with malignancy. Contrast enhancement is found inconsistently in both malignant gliomas and low-grade tumors and thus is not a reliable prognostic indicator. In our study, the degree of enhancement was nearly the same for all tumor grades (Fig. 2B ). There were also very similar blood-brain barrier impairments in tumors of all grades. In the four cases of nontumorous lesions, the somatosensory and auditory evoked potentials were not diagnostically helpful. The CSF was examined in only two cases, one involving an unclear, nontumor finding on MR imaging, which was subsequently identified as a developmental venous anomaly, and the other involving lymphohistiocytic granuloma. In both cases, the CSF analysis was nondiagnostic. As is often the case in posterior cranial fossa disease, no lumbar puncture was performed in the other two patients with nontumorous lesions to avoid the risk of herniation through the foramen magnum.
The correlation between blinded observers' interpretations of MR images and histopathological findings is not fully representative of the accuracy of imaging because there was an inherent bias in this study due to the inclusion criteria. Because of the retrospective study design and the exclusion of cases in which biopsies were not performed, nontumorous lesions were underrepresented in our sample. We have to assume that the cases in which biopsy was performed were those in which the MR imaging studies raised the suspicion of tumor. Because biopsy is associated with a morbidity rate between 2 and 9% and a mortality rate between 0.05 and 2.6%, 1, 32, 39, 42 biopsy is generally recommended only for cases in which a tumor is the leading possibility in the differential diagnosis. We could not assess interobserver agreement because of the small numbers of nontumorous lesions, despite the fact that the observers were blinded to the histological findings when they reviewed the MR images.
Tumors were identified correctly in 95 to 99% of the cases overall; reliability was somewhat lower for the identification of tumors in the glioma subgroup (range 85-91%; Table 3 ). The interrater differences for tumor grading were high. The maximum variability was 54% and occurred in the estimation of Grade IV tumors. The high interrater reliability for differentiating tumors from nontumorous lesions may again be explained by the selection bias in favor of tumor cases, whereas the lower identification rate for gliomas demonstrates the lower specificity of MR imaging for the differentiation of tumor type (Table 3) . Knowledge of clinical history, for example the duration of clinical symptoms, did not improve the results, despite the fact that high-grade tumors are typically characterized by more rapid disease progression (that is, a shorter history of symptoms). This phenomenon has been observed in other papers, in which authors have reported that sensitivity in interpretation of MR images is not measurably improved by awareness of clinical data. 41 The observers were able to identify brainstem tumors on MR images in the majority of cases in our study, but nontumorous lesions were misdiagnosed as tumors in one quarter to one half of the cases (Table 5 ). Although our data did not provide definite confirmation of the MR imaging characteristics that most strongly suggest the probability of a nontumorous brainstem lesion, we did find that the diagnosis of tumor could be made in most cases (Fig. 5) . The accuracy of MR imaging for the diagnosis of gliomas (range 85-91%) in our study corresponds approximately to the accuracy of intraoperative diagnosis (81%) that has been reported for the agreement between intraoperative and final histological diagnoses. 39 The general diagnosis of tumor was correctly determined from MR images in at least 95% of the cases in our study. Again, this accuracy rate is in keeping with the reported finding that 4.6% of biopsies do not lead to a diagnosis. 39 In the results of our study, the problems of interobserver nonconcordance of the neuropathologists' diagnoses are not taken into consideration. Thus, there is generally an indication for a biopsy only when MR imaging findings are atypical. In most cases, therapy can be planned according to clinical and radiological criteria (Table 7) , 36 especially since it has been demonstrated that knowledge of the histologically determined tumor grade has no influence on the choice of therapy in most cases. 1, 3 Finally the valuable information obtained through clinical and imaging follow up (Fig. 6 ) can more extensively be used for differential diagnosis of brainstem diseases.
Conclusions
The debate concerning the need for histopathological diagnosis in brainstem lesions has been based for years on the level of visualization possible with CT. Given the improved differentiation of tumors from nontumorous lesions that is afforded by MR imaging, the shortcomings of biopsy-including the possibility of error, the risk of morbidity, and the limited relevance to choice of therapy-require that its use be critically reconsidered. In most cases, tumors can be distinguished from nontumorous lesions without direct histological examination when all diagnostic criteria, such as clinical history, signs and symptoms, and laboratory data (CSF analysis, infectious parameters, immunological findings), as well as the results of MR imaging studies (including serial follow-up studies) are taken into account. In light of these considerations, biopsy should be reserved for atypical cases. 6 . Magnetic resonance image obtained in an 18-year-old boy who presented with headache and facial paresis. The lesion was a contrast-enhancing lymphohistiocytic granuloma (confirmed by stereotactic biopsy). Laboratory tests for tuberculous, viral, bacterial, and mycotic pathogens were negative. There was a complete regression of the lesion 4 weeks after the biopsy (not shown). "Wait and see" would have been an acceptable strategy in a lesion of this small size with only scant edema.
